COLBY PHARMACEUTICAL
Colby Pharmaceutical is developing next-generation safe and effective drugs for inflammatory conditions. Colby products are designed to provide patients with faster-acting, longer-lasting, dose sparing, safer, higher efficacy, and more cost-effective therapeutic drugs.
COLBY PHARMACEUTICAL
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Website Url:
http://www.colbypharmaceuticals.com
Status:
Active
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ellodi Pharmaceuticals
Ellodi Pharmaceuticals focuses on studying about treatment of Eosinophilic Esophagitis, an inflammatory condition.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
OLAS Pharmaceuticals
Olas Pharmaceuticals, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California and is no longer active.
Overa, Inc.
Overa is developing next-generation female contraception
Pharmalundensis
Pharmalundensis develops an effective drug against the closely associated lung diseases COPD and chronic bronchitis.
Sitari Pharmaceuticals
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-09-19 | Othera Pharmaceuticals | Othera Pharmaceuticals acquired by Colby Pharmaceutical | N/A |
Official Site Inspections
http://www.colbypharmaceuticals.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 13.248.243.5
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
